Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs.
Salmonella typhimurium SL3261 (aroA mutant) expressing a recombinant Mycoplasma hyopneumoniae antigen was used to orally immunize swine against porcine enzootic pneumonia. This construct, designated S. typhimurium aro A SL3261 (pKF1), expressed a recombinant protein containing the carboxy-terminal 11 kDa of a 42 kDa M. hyopneumoniae NrdF ribonucleotide reductase R2 subunit protein. Here we demonstrate that this antigen is present in all seven geographically diverse strains of M. hyopneumoniae tested, and is recognized by the swine immune system after experimental infection with the virulent M. hyopneumoniae Beaufort strain. The immune response of swine orally immunized twice with S. typhimurium SL3261 (pKF1) on day 0 and day 14 was evaluated. Oral immunization with S. typhimurium SL3261 (pKF1) primed the immune system to elicit a significant (P<0.05) secretory IgA response against the 15 kDa NrdF antigen in the respiratory tract of swine, post-challenge, compared to control groups. Blood lymphocytes from swine immunized with S. typhimurium SL3261 (pKF1) proliferated significantly (P<0.05) following stimulation with M. hyopneumoniae whole-cell extracts compared to control groups 14 days post-vaccination. Following challenge with virulent M. hyopneumoniae, swine immunized with S. typhimurium SL3261 (pKF1) showed higher average daily weight gains and reduced lung pathology compared to control groups.
Fagan
P K
PK
Department of Biological Sciences, University of Wollongong, Camden, N.S.W., Australia.
Walker
M J
MJ
Chin
J
J
Eamens
G J
GJ
Djordjevic
S P
SP
D000284:Administration, Oral; D000818:Animals; D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology; D001426:Bacterial Proteins; D007114:Immunization; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D008168:Lung / Q000276:immunology; D009174:Mycoplasma / Q000235:genetics / Q000276:immunology; D018410:Pneumonia, Bacterial / Q000662:veterinary*; D011994:Recombinant Proteins / Q000276:immunology / Q000378:metabolism; D012264:Ribonucleotide Reductases / Q000235:genetics / Q000276:immunology*; D022562:Salmonella Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000378:metabolism; D013552:Swine; D013553:Swine Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000378:metabolism
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D007071:Immunoglobulin A, Secretory; D011994:Recombinant Proteins; D022562:Salmonella Vaccines; D014436:Typhoid-Paratyphoid Vaccines; C087350:aroA Salmonella vaccine; C114872:NrdF protein, bacteria; D012264:Ribonucleotide Reductases